In a sweeping crackdown on healthcare fraud, seven individuals and associated entities across five states have shelled out more than $1.5 million to settle charges of running kickback schemes that tarnished the medical industry. The accused parties, including two laboratory marketers and five physicians, allegedly traded cash for Medicare referrals, flouting federal laws designed to maintain the integrity of medical decisions. These settlements come as a firm reminder that manipulating the healthcare system for ill-gotten gains is a costly misstep.
Among the marketers, George Carralejo and his firm, OC Genetic Consultants Inc., agreed to pay $400,000 after the Justice Department accused them of conspiring in two separate instances to funnel illegal payments to doctors for lab test referrals. In contrast, Michael Jeresaty and his company, Ralston, settled to pay $320,000 over allegations of greasing the palms of physicians to secure those valuable referrals—a clear signal that the government is tightening the reins on backdoor dealings in the healthcare sector, according to a statement obtained by the Justice Department.
The settlements also divulge that five doctors were part of the schemes, with Dr. Paul Bierig of Texas, for instance, agreeing to a $120,634 payout to clear allegations of receiving kickbacks from management service organizations (MSO), in exchange for laboratory test referrals to RDx and RealLab. On the list, Dr. Mohd Azfar Malik paid $217,430 for his participation in a similar arrangement involving Genesis and InHealth diagnostic labs. Payouts by Dr. Robert Ain, and Drs. Barry and Rachel Feinberg further highlight the widespread nature of these corrupt practices.
"Kickbacks can harm taxpayer-funded healthcare programs, distort the market for healthcare services and improperly influence healthcare providers' medical decisions," stated Principal Deputy Assistant Attorney General Brian M. Boynton, reflecting the gravity of the offenses designed to line pockets at the expense of medical objectivity and due process. No doubt these bad actors are swiftly feeling the weight of justice, with settlements serving both as a deterrent and a combative measure, reinforcing a stance against schemes that threaten the sanctity of healthcare services and decision-making, states Boynton in his stern rebuke.
Investigators from various branches including the Civil Division's Commercial Litigation Branch, Fraud Section, and U.S. Attorney's Office for the District of New Jersey worked alongside the Department of Health and Human Services, Office of Inspector General (HHS-OIG) to bring the offenders to book. The United States has clawed back over $47 million tied to MSO kickback conduct, showing that while the schemes may be intricate, they are not beyond the reach of relentless federal scrutiny. Special Agent in Charge Naomi D. Gruchacz of HHS-OIG attests to the ongoing efforts to "preserve the integrity of the federal health care system." These settlements are a sobering reminder to those in the healthcare industry that the shortcut of corruption is ultimately a dead end.
